Results 81 to 90 of about 12,387 (203)
Investigation of the expression profile of streptokinase [PDF]
, 2009 Streptococcus pyogenes (group A streptococcus; GAS) is a Gram-positive bacterium that causes invasive and non invasive infections in human skin and mucosal tissue.
Priya Shyam (20280687)
core
Multiple Exosites Distributed across the Three Domains of Streptokinase Co-Operate to Generate High Catalytic Rates in the Streptokinase–Plasmin Activator Complex [PDF]
, 2016 To examine the global function of the key surface-exposed loops of streptokinase, bearing substrate-specific exosites, namely, the 88–97 loop in the α domain, the 170 loop in the β domain, and the coiled-coil region (Leu321-Asn338) in the γ domain ...
Girish Sahni (1872853) +3 more
core +1 more source
TITANIUM NANOPARTICLES CONJUGATED WITH STREPTOKINASE AS A MODIFIED THROMBOLYTIC AGENT [PDF]
, 2020 Objective: Blood clots are the main cause of death worldwide by stroke and myocardial infarction. Streptokinase a thrombolytic agent that is used in the treatment of circulatory disorders.
ABED, HAYDER H. +2 more
core +1 more source
Ancient Science of Life, 2017 Aims and Objectives: In vitro evaluation and comparison of thrombolytic activity of raw and purified bhallātaka (Semecarpus anacardium Linn.f.) nuts by means of % of clot lysis.
Dattatray D Sarvade +2 more
doaj +1 more source
Influence of adenylic nucleotides on the activating function of streptokinase [PDF]
, 1987 The addition of ATP or 3,5-AMP (but not UTP, GTP, CTP, AMP, 2,3-AMP, ADP, inorganic pyrophosphate) at a final concentration of 10 - 1 M into streptokinase solution, pH 7.0 or 9.5, causes a dramatical inhibition of streptokinase-induced fibrinolysis.
Пыжова, Н.С. +5 more
core
Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, 2009 BACKGROUND AND OBJECTIVE: Streptokinase (SK) is a microbial plasminogen-activator that is used in the treatments, especially at Acute ischemic stroke, declotting of dialysis shunts and inflammatory antibiotic-resistant prostatitis.
MR Nejadmoghaddam, +2 more
doaj
INDIGENOUS RECOMBINANT STREPTOKINASE VS NATURAL STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION PATIENTS: PHASE III MULTICENTRIC RANDOMIZED DOUBLE BLIND TRIAL [PDF]
, 2005 Background : Streptokinase is the most widely used thrombolytic agent and can now be made using recombinant DNA technology. The present trial was initiated to assess an indigenous recombinant streptokinase (Shankinase, r-SK).
S. K. Diwedi +10 more
core +1 more source
Bangladesh Journal of Pharmacology, 2008 A prospective interventional study was carried out to compare the thrombolytic effect of streptokinase between diabetic and non-diabetic myocardial infarction patients.
Md. Anup Rahman Chowdhury +4 more
doaj +1 more source
Streptokinase in Acute Ischemic Stroke: An Individual Patient Data Meta-Analysis [PDF]
, 2000 Background and Purpose —Three major randomized controlled trials of streptokinase in acute ischemic stroke were curtailed because of safety concerns.
L. Candelise +7 more
core +1 more source
Door to Needle Time and its Impact on Successful Thrombolysis
Journal of Rawalpindi Medical College, 2012 Background: To evaluate the Door to needle time and its impact on successful thrombolysis . Methods : In this cross sectional study all patients admitted with Acute Myocardial Infarction (AMI), who were candidates for fibrinolysis, were included ...
Sarfaraz Ali Zahid
doaj